Target intelligence / Profile preview

Neurotrophic factor release (by mesenchymal stem cells)

Molecular classification
Other (Cell biological process, Paracrine factor release), Not a member of classifications like receptor, enzyme, ion channel, etc.
01

Overview

Neurotrophic factor release supporting nerve repair/regeneration by mesenchymal stem cells refers to the process by which MSCs secrete a combination of growth factors, cytokines, and neurotrophins—including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), ciliary neurotrophic factor (CNTF), and others—that promote neuronal survival, axonal outgrowth, remyelination, and functional recovery after nerve injury. This secretion is largely paracrine, modulating the immune environment, supporting angiogenesis, and reducing cell death, and is considered the primary mechanism by which MSCs exert neuroregenerative effects. Currently, clinical translation is limited by safety, efficacy variability, and incomplete mechanistic understanding.

Other names
MSC-mediated neurotrophic factor secretionMSC secretome (neurotrophic component)Paracrine support for nerve regeneration by MSCs
02

Mechanism of action

Paracrine secretion of neurotrophic factors (NGF, BDNF, GDNF, CNTF, etc.) supporting neuronal survival and axonal regeneration Immunomodulation (secretion of anti-inflammatory cytokines and growth factors) Enhancement of angiogenesis via released factors (VEGF, HGF, IGF) Inhibition of scar tissue formation

03

Biological functions

Promotion of nerve regenerationNeuroprotectionCell survivalAnti-apoptosisImmune modulationAngiogenesis
04

Disease associations

Neurodegenerative diseasePeripheral nerve injuryNeuropathic painSpinal cord injuryInflammation
05

Safety considerations

Potential for immunogenic reactionsTumorigenic risk (minimal in cell-free/secreteome approaches)Ethical concerns (tissue sourcing)Variable efficacy due to heterogeneity of MSC secretomesLimited translation from animal to human studies
06

Biomarkers

Levels of released neurotrophic factors (NGF, BDNF, GDNF, CNTF) in the injured tissueMSC-derived exosome miRNAsLocal cytokine profiles (e.g., IL-10, TGF-β)

Beyond the preview

Go deeper on Neurotrophic factor release (by mesenchymal stem cells).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotrophic factor release (by mesenchymal stem cells).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call